Stay updated on Isatuximab Combo in High-Risk Smoldering MM Clinical Trial
Sign up to get notified when there's something new on the Isatuximab Combo in High-Risk Smoldering MM Clinical Trial page.

Latest updates to the Isatuximab Combo in High-Risk Smoldering MM Clinical Trial page
- Check3 days agoChange DetectedThe version history now includes an added entry for Revision: v3.6.2, replacing Revision: v3.6.0 to reflect a platform update.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe history adds a recruitment-status update indicating the study is no longer enrolling participants, and records a page revision to v3.6.0 (with the previous v3.5.5 revision removed).SummaryDifference0.3%

- Check24 days agoChange DetectedThe history now shows the latest revision label as v3.5.5 and removes the previous v3.5.4 entry, updating the record's revision trail.SummaryDifference0.1%

- Check39 days agoChange DetectedThe record history now shows Revision: v3.5.4 added and Revision: v3.5.3 removed, indicating an update to the page's revision metadata.SummaryDifference0.1%

- Check60 days agoChange DetectedThe Record History shows a new page revision: Revision: v3.5.3, replacing the previous Revision: v3.5.2. This indicates the page has been updated to a newer version.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision notes show the site updated from v3.5.0 to v3.5.2. This appears to be a software version update reflected in the page footer.SummaryDifference0.1%

Stay in the know with updates to Isatuximab Combo in High-Risk Smoldering MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab Combo in High-Risk Smoldering MM Clinical Trial page.